Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Non-Hodgkin's Lymphoma treatment details. Biologic therapy. Radiation. Korea Cancer Center Hospital, Seoul, Korea



Survival: 11.3 months
   
Toxicity Grade: 5
   
Treatments: Biologic therapy
Radiation
   
Drugs:
Country: Korea
   
City/State/Province: Seoul
   
Hospital: Korea Cancer Center Hospital
   
Journal: Link
   
Date: 6/2011

Description:
Patients:
This study involved 24 non-Hodgkin’s lymphoma patients with a median age of 63 years; 75% were male.

Treatment:
Patients received radioimmunotherapy with the biologic therapy agent rituximab (an antibody that recognizes the CD20 protein and targets cancer cells to be killed by the immune system) that was combined with radioactive particles.

Toxicities:
There was one treatment-related death reported for this study. Grade 4 neutropenia, thrombocytopenia, and anemia were also reported.

Results:
The median overall survival was 11.3 months.

Correspondence: Dr. Sang Moo Lim; email: smlim328@kcch.re.kr

E-mail to a Friend Email Physician More Information